{"id":330541,"date":"2020-12-24T14:30:37","date_gmt":"2020-12-24T13:30:37","guid":{"rendered":"https:\/\/medizinonline.com\/modulo-de-leucemia-mieloide-aguda\/"},"modified":"2023-01-11T13:30:13","modified_gmt":"2023-01-11T12:30:13","slug":"modulo-de-leucemia-mieloide-aguda","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/es\/modulo-de-leucemia-mieloide-aguda\/","title":{"rendered":"M\u00f3dulo de leucemia mieloide aguda"},"content":{"rendered":"\n<p>Despu\u00e9s de muchos a\u00f1os sin avances terap\u00e9uticos apreciables, recientemente se ha dispuesto de una serie de nuevas opciones de tratamiento para la leucemia mieloide aguda, que podr\u00edan mejorar la situaci\u00f3n de los afectados. Prof. em. El Dr. Richard Herrmann interviene en el m\u00f3dulo sobre leucemia mieloide aguda de Swiss Oncology in Motion con el Dr. Mario Bargetzi (Kantonsspital Aarau), el Dr. Rouven M\u00fcller (USZ Z\u00farich) y el Dr. Georg St\u00fcssi (IOSI, Tesino).<\/p>\n\n<!--more-->\n\n<p><strong>Moderaci\u00f3n:<\/strong><\/p>\n\n<p>Richard Herrmann, MD, Prof. em. para Oncolog\u00eda, Riehen\/Basilea<\/p>\n\n<p><em>Los siguientes v\u00eddeos pueden verse en modo de pantalla completa haciendo clic con el bot\u00f3n derecho del rat\u00f3n y pulsando despu\u00e9s &#8220;Abrir fotograma en una pesta\u00f1a&#8221;. <\/em><\/p>\n\n<p><strong>Leucemia mi\u00f3lica aguda: aspectos b\u00e1sicos de la enfermedad (1\u00aa parte)<\/strong><br\/>Prof. Dr. med. Mario Bargetzi, M\u00e9dico Jefe de Hematolog\u00eda, Hospital Cantonal de Aarau<\/p>\n\n<p><iframe data-src=\"https:\/\/player.vimeo.com\/video\/609572899?h=149a982191\" width=\"640\" height=\"427\" frameborder=\"0\" src=\"data:image\/svg+xml;base64,PHN2ZyB3aWR0aD0iMSIgaGVpZ2h0PSIxIiB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciPjwvc3ZnPg==\" class=\"lazyload\" data-load-mode=\"1\"><\/iframe><\/p>\n\n<p><strong>Opciones de tratamiento para pacientes en forma (2\u00aa parte)<\/strong><br\/>Dr. Rouven M\u00fcller, m\u00e9dico jefe, FHM Hematolog\u00eda, USZ Z\u00farich<\/p>\n\n<p><iframe data-src=\"https:\/\/player.vimeo.com\/video\/609576542?h=9a16ed1fbd\" width=\"640\" height=\"416\" frameborder=\"0\" src=\"data:image\/svg+xml;base64,PHN2ZyB3aWR0aD0iMSIgaGVpZ2h0PSIxIiB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciPjwvc3ZnPg==\" class=\"lazyload\" data-load-mode=\"1\"><\/iframe><\/p>\n\n<p><strong>Opciones para pacientes no tratables intensivamente y nuevos enfoques (Parte 3)<\/strong><br\/>Prof. Dr. med. Georg St\u00fcssi Jefe de Hematolog\u00eda del Instituto de Oncolog\u00eda de la Suiza italiana (IOSI)<\/p>\n\n<p><iframe data-src=\"https:\/\/player.vimeo.com\/video\/609581411?h=1492b83a1b\" width=\"640\" height=\"416\" frameborder=\"0\" src=\"data:image\/svg+xml;base64,PHN2ZyB3aWR0aD0iMSIgaGVpZ2h0PSIxIiB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciPjwvc3ZnPg==\" class=\"lazyload\" data-load-mode=\"1\"><\/iframe><\/p>\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Despu\u00e9s de muchos a\u00f1os sin avances terap\u00e9uticos apreciables, recientemente se ha dispuesto de una serie de nuevas opciones de tratamiento para la leucemia mieloide aguda, que podr\u00edan mejorar la situaci\u00f3n&hellip;<\/p>\n","protected":false},"author":12,"featured_media":377070,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Formaci\u00f3n en l\u00ednea Oncolog\u00eda suiza en movimiento","footnotes":""},"category":[11296,11478,11336,11552],"tags":[],"powerkit_post_featured":[],"class_list":["post-330541","post","type-post","status-publish","format-standard","has-post-thumbnail","category-contenido-para-socios","category-formacion-continua","category-oncologia","category-rx-es","pmpro-has-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-04-20 13:31:31","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"es_ES","wpml_translations":[],"_links":{"self":[{"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/posts\/330541","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/users\/12"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/comments?post=330541"}],"version-history":[{"count":1,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/posts\/330541\/revisions"}],"predecessor-version":[{"id":330542,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/posts\/330541\/revisions\/330542"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/media\/377070"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/media?parent=330541"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/category?post=330541"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/tags?post=330541"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/powerkit_post_featured?post=330541"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}